1. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen

   • Mikio Igawa
   • Hitoshi Kadena
   • Tsuguru Usui

   Session 1: Advance Bladder Cancer Pages: S1 - S4

2. The effect of dose intensity on M-VAC therapy for advanced urothelial cancer

   • Naoto Miyanaga
   • Hideyuki Akaza
   • Kenkichi Koiso

   Session 1: Advance Bladder Cancer Pages: S5 - S8

3. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer

   • Masao Kuroda
   • Norio Meguro
   • Toshihiko Kotake

   Session 1: Advance Bladder Cancer Pages: S9 - S13

4. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis

   • Hiroaki Kobayashi
   • Koji Obata

   Session 1: Advance Bladder Cancer Pages: S14 - S17

5. Chemotherapy for endocrine-therapy-refractory prostate cancer

   • Susumu Akimoto
   • Takemasa Ohki
   • Jun Shimazaki

   Session 2: Prostate Cancer Pages: S18 - S22

6. Chemo-endocrine therapy for prostate cancer with bone metastasis

   • Hideki Sakai
   • Yuzo Minami
   • Nagasaki Prostate Cancer Research Group

   Session 2: Prostate Cancer Pages: S23 - S26

7. Intra-arterial chemotherapy using a reservoir for endocrine-refractory prostate cancer

   • Manabu Kuriyama
   • Toshimi Takeuchi
   • Yukimichi Kawada

   Session 2: Prostate Cancer Pages: S27 - S30

8. A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer

   • Kikuo Okamura
   • Tatsuro Murase
   • The Nagoya University Urological Oncology Group

   Session 3: Superficial Bladder Cancer Pages: S31 - S35

9. Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory

   • Yoshihiko Hirao
   • Seiichiro Ozono
   • Members of Nara Uro-oncology Research Group (NUORG)

   Session 3: Superficial Bladder Cancer Pages: S36 - S40

10. Prophylactic chemotherapy with anthracyclines (Adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer

    • Nobuo Shinohara
    • Katsuya Nonomura
    • The Hokkaido University Bladder Cancer Collaborative Group

    Session 3: Superficial Bladder Cancer Pages: S41 - S45

11. Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial

    • Hiroshi Eto
    • Yasuhiko Oka
    • Kobe University Urological Oncology Group

    Session 3: Superficial Bladder Cancer Pages: S46 - S51

12. A phase II study of prophylactic intravesical chemotherapy with 4′-epirubicin in recurrent superficial bladder cancer: comparison of 4′-epirubicin and Adriamycin

    • Taro Shuin
    • Yoshinobu Kubota
    • Hiroshi Fukuoka

    Session 3: Superficial Bladder Cancer Pages: S52 - S56

13. Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors

    • Nobuyuki Watanabe
    • Ikuo Miyagawa
    • Tottori University Oncology Group

    Session 3: Superficial Bladder Cancer Pages: S57 - S59

14. A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer

    • Osamu Ryoji
    • Hiroshi Toma
    • Tokyo Women's Medical College Bladder Cancer Collaborating Group

    Session 3: Superficial Bladder Cancer Pages: S60 - S64

15. The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report

    • Yasunari Uekado
    • Atsuyuki Hirano
    • Tadashi Ohkawa

    Session 3: Superficial Bladder Cancer Pages: S65 - S68

16. Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial

    • Tomoyasu Tsushima
    • Hiroyuki Ohmori
    • Yasuo Ohashi

    Session 3: Superficial Bladder Cancer Pages: S69 - S75

17. Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results

    • Seiji Naito
    • Toyofumi Ueda
    • The Kyushu University Urological Oncology Group

    Session 3: Superficial Bladder Cancer Pages: S76 - S80

18. Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma

    • Kousuke Ueda
    • Hiroshi Sakagami
    • Takehiko Okamura

    Session 3: Superficial Bladder Cancer Pages: S81 - S83

19. Studies of effects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique

    • Tadao Uchibayashi
    • Soo-Woong Lee
    • Takuma Sasaki

    Session 3: Superficial Bladder Cancer Pages: S84 - S87

20. Prophylactic chemotherapy with intravesical instillation of Adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer

    • Koji Obata
    • Yasuo Ohashi
    • The Japanese Urological Cancer Research Group for Adriamycin

    Session 3: Superficial Bladder Cancer Pages: S88 - S92

21. Advanced bladder cancer: options of therapy

    • J. Edson Pontes

    Session 4: State of the Art in Urinary Tract Tumors Pages: S93 - S96

22. Experiences with doxo/epirubicin and medroxyprogesterone acetate (MPA) in prostatic cancer

    • Claes Anderström

    Session 4: State of the Art in Urinary Tract Tumors Pages: S97 - S100

23. Superficial bladder cancer: state of the art

    • A. V. Bono

    Session 4: State of the Art in Urinary Tract Tumors Pages: S101 - S109